Purchases and Sales Made in Q2 2023 in Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX) during Q2 2023. The information is specifically focused on institutions that hold shares of Protagonist Therapeutics, Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-771K- 68.65% |
$13.9M - $22.6M
|
352K
$13.7M
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-992K- 63.2% |
$17.9M - $29.1M
|
578K
$22.6M
|
|
|
Aug 14, 2023
Q2 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-1.2M- 87.96% |
$21.7M - $35.3M
|
165K
$6.42M
|
|
|
Aug 14, 2023
Q2 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-1.27M- 49.46% |
$22.8M - $37.1M
|
1.29M
$50.4M
|